Pharma China (www.pharmachinaonline.com) is the most influential English media and source of business intelligence covering the Chinese pharmaceutical sector. Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most MNC pharma companies, leading CROs, investment banks, consulting firms active in China as well as relevant industry associations and government agencies.

Note: To view full text of free articles, you need to register as a basic member first and then log in. To view premium articles, you need to subscribe to Pharma China as a premium member. For more information or subscription, please contact info@pharmachinaonline.com. If you wish to unsubscribe from this e-Alert, please reply this e-mail with "Remove" in the subject line.
Industry News
CDE Publicizes 18 Drug Applications To Be Granted Priority Review Status(9/16/2019 )  (Premium)
Helsinn and Mundipharma Announce Chinese Approval of Akynzeo Oral Formulation(9/16/2019 )  (free)
Regulatory News
NMPA Publicizes List of Reference Formulations for Generic Drug Equivalence Studies (24th Batch)(9/16/2019 )  (Premium)
General Health
China to Raise BMI Reimbursement of Outpatient Diabetes and Hypertension Drugs to Above 50%(9/16/2019 )  (Premium)
China Begins Mapping Standards for 5G-based Hospitals(9/16/2019 )  (Premium)
China Sees Rising Number of Nurses(9/16/2019 )  (free)
© Wicon International GroupˇˇSupport by: www.heightow.com Home | Site map | Contact Us | Links